Accuracy of Revised Tokuhashi Scoring System and Prognostic Factors to Predict Life Expectancy in Lung Cancer Patients with Spinal Metastasis
Keywords:neoplasm, lung cancer, spinal metastasis, prognosis, life expectancy, scoring system
Purpose: This study aimed to verify the accuracy of the revised Tokuhashi scoring system to identify the prognosis and life expectancy of lung cancer patients with spinal metastasis. We also aimed to find the factors that were related to the prognosis and actual death.
Method: Lung cancer patients with spinal metastasis who were diagnosed between January 2014 to December 2018 were included in this study. Demographic data, radiographic data, revised Tokuhashi score parameters, actual death, and treatment administered were collected from the hospital tumor database. The relationship between each parameter and actual death were collected and multivariable logistic regression analysis was used to explore the associated factors.
Results: Totally 181 patients were included in this study. The accuracy of the revised Tokuhashi scoring system in this study was 80.68% for scores 0-8 and 100% for scores ≥ 9. Sensitivity and specificity were 100%and 80.7%, respectively, for the prediction of life expectancy ≥ 6 months. LR+ was 5.18. Female (HR=0.58, P=0.001), good general condition (HR=0.34, P=0.036), none of extra spinal foci metastasis (HR=0.40, P=0.002), 1 or 2 extra spinal foci metastasis (HR=0.54, P=0.003), radiation (HR=0.57, P=0.02), and chemotherapy (HR=0.51, P=0.004) were the associated factors with statistical significance.
Conclusion: The revised Tokuhashi scoring system for lung cancer with spinal metastasis had satisfactory accuracy rate to predict life expectancy, especially for > 6 months (score ≥ 9). We also found that females, good general condition, number of extra spinal foci < 3, radiation, and chemotherapy were significantly good prognoses for life expectancy.
Houston KA, Henley SJ, Li J, et al. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009. Lung Cancer 2014;86:22-8.
Lortet-Tieulent J, Soerjomataram I, Ferlay J, et al. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer 2014;84:13-22.
Haba H, Taneichi H, Kotani Y, et al. Diagnostic accuracy of magnetic resonance imaging for detecting posterior ligamentous complex injury associated with thoracic and lumbar fractures. J Neurosurg 2003;99(1 Suppl):20-6.
Tokuhashi Y, Kawano H, Ohsaka S, et al. [A scoring system for preoperative evaluation of the prognosis of metastatic spine tumor (a preliminary report)]. Nihon Seikeigeka Gakkai Zasshi 1989;63:482-9.
Tokuhashi Y, Matsuzaki H, Toriyama S, et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 1990;15:1110-3.
Enkaoua EA, Doursounian L, Chatellier G, et al. Vertebral metastases: a critical appreciation of the preoperative prognostic tokuhashi score in a series of 71 cases. Spine (Phila Pa 1976) 1997;22: 2293-8.
Tomita K, Kawahara N, Baba H, et al. Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine (Phila Pa 1976) 1997;22:324-33.
Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001;26:298-306.
Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30:2186-91.
Quraishi NA, Manoharan SR, Arealis G, et al. Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC). Eur Spine J 2013;22(Suppl 1):S21-6.
Uei H, Tokuhashi Y. Prognostic factors in patients with metastatic spine tumors derived from lung cancer-a novel scoring system for predicting life expectancy. World J Surg Oncol 2018;16:131.
Uei H, Tokuhashi Y, Maseda M. Treatment outcome of metastatic spine tumor in lung cancer patients: Did the treatments improve their outcomes?. Spine (Phila Pa 1976) 2017;42: E1446-51.
Zhang L, Gong Z. Clinical characteristics and prognostic factors in bone metastases from lung cancer. Med Sci Monit 2017;23:4087-94.
Yuk-Nam Y, Ka-Kin C, Tai-Chung L, et al. A study of the predictive value of the modified tokuhashi score in metastatic spinal tumour causing cord compression in a Southern Chinese population. J Orthop Trauma Rehabil 2014;18: 15-21.
Sioutos PJ, Arbit E, Meshulam CF, et al. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer 1995;76:1453-9.
Gao Z-Y, Zhang T, Zhang H, et al. Establishment and validation of nomogram model for survival predicting in patients with spinal metastases secondary to lung cancer. Neurol Res 2021;43: 327-35.
Lun D-X, Chen N-W, Feng J-T, et al. Visceral metastasis: A prognostic factor of survival in patients with spinal metastases. Orthop Surg 2020;12:552-60.
Gong L, Xu L, Yuan Z, et al. Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis. J Bone Oncol 2019;19:100265.
Yang X-G, Lun D-X, Hu Y-C, et al. Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis. BMC Cancer 2018;18:1248.
Padalkar P, Tow B. Predictors of survival in surgically treated patients of spinal metastasis. Indian J Orthop 2011;45:307-13.
Truong VT, Shedid D, Al-Shakfa F, et al. Surgical intervention for patients with spinal metastasis from lung cancer: A retrospective study of 87 cases. Clin Spine Surg 2021;34:E133-40.
Lin H-H, Chiu C-H, Chou P-H, et al. Functional outcomes and survival after surgical stabilization for inoperable non-small-cell lung cancer with spinal metastasis of the thoracic and lumbar spines: a retrospective comparison between epidermal growth factor receptor-tyrosine kinase inhibitor and platinum-based chemotherapy groups. Spinal Cord 2020;58:194-202.
How to Cite
Copyright (c) 2022 The Royal College of Orthopaedic Surgeons of Thailand
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.